# FDA
Latest news and articles about FDA
Total: 2 articles found
Chinese Drugmaker Wins FDA Green Light to Test Next‑Generation Obesity Peptide in the US
Shiyao Group has won FDA permission to begin US clinical trials of a long‑acting peptide that acts on both GLP‑1 and GIP receptors for weight management in people with obesity or overweight plus comorbidities. The clearance permits investigational trials but falls short of marketing approval; success would boost China’s ambitions to compete in the lucrative obesity‑drug market dominated by Western firms.
First Inhaled Gene Therapy for Lung Cancer Wins FDA Fast‑Track Nod, Raising Hopes — and Questions
An inhaled gene therapy targeting lung cancer has shown promising early clinical efficacy and received FDA RMAT designation and fast‑track status. The move accelerates regulatory review but leaves open critical questions about safety, durability, manufacturing and who will ultimately benefit.